Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS

Clinical trial NCT07076186 · SUSPENDED

Trial details

NCT number: NCT07076186
Sponsor: M.D. Anderson Cancer Center
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Leiomyosarcoma

Start date: 2025-10-02
Primary completion: 2027-12-02
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.